XML 33 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Information

Note 19 – Segment Information

 

The Company is an operating, acquisition, and investment business. Subsidiaries in which the Company has a controlling financial interest are consolidated. The Company generally has two reportable segments; 1) the historic cannabis and medical marijuana segment which includes the cost basis of our former membership interests of Electrum, the former contractual interest in the Electrum legal recovery, the settlement payments receivable from G Farma and its co-defendants, the former finance lease payments receivable from Pueblo West to Partner II, the operation of subsidiaries MCIP and Partner I in the cannabis and medical marijuana sector, and 2) the Company’s long standing investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their facility related operating costs. Additionally, the Company formerly had small investments in securities listed on the NYSE and NASDAQ, an investment in note receivable from a non-affiliated party, the fair value of convertible notes receivable and accrued interest from NeuCourt, which on July 15, 2022 was exchanged for a NeuCourt SAFE security investment that will be carried at cost, and the investment in NeuCourt that is included in the Corporate, Other, and Eliminations section below.

  

   Cannabis and Medical Marijuana Segment   Facility Operations Related   Corporate and Eliminations   Consolidated 
                 
Three months ended March 31, 2023                    
Net revenue  $-   $2,175,135   $-   $2,175,135 
Operating income (loss)   (706)   244,054    (170,734)   72,614 
Interest income   -    -    6,660    6,660 
Interest expense   -    16,163    2,796    18,959 
Property additions   -    -    -    - 
Depreciation and amortization   -    14,208    238    14,446 
Total assets   812    3,623,663    1,607,618    5,232,093 
                     
Three months ended March 31, 2022                    
Net revenue  $9,017   $1,839,881   $-   $1,848,898 
Operating income (loss)   5,491    187,150    (161,265)   31,376)
Interest income   -    -    14,353    14,353 
Interest expense   -    10,386    7,821    18,207 
Property additions   -    27,902    -    27,902 
Depreciation and amortization   -    15,368    522    15,890 
Total assets   879,789    2,411,343    1,545,786    4,836,918 

 

 

Note 19 – Segment Information (continued)

 

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

  

   2023   2022 
   Three Months Ended
March 31,
 
   2023   2022 
Operating loss  $72,614   $31,376 
Gain (loss) on investments   -    (42,680)
Interest income   6,660    14,353 
Interest expense   (18,959)   (18,207)
Gain (loss) on ROU asset disposal   -    26,168 
Other income   12,118    1,500 
           
Income before income taxes  $72,433   $12,510